Strides Pharma Science Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science has informed the stock exchanges that its trading window will be closed starting July 1, 2025, until 48 hours after the company declares its financial results for the quarter ended June 30, 2025. This is a mandatory compliance step under SEBI's Insider Trading Regulations, which restricts designated employees and insiders from trading in the company's shares during this period. The exact date of the board meeting to approve the Q1 FY26 results has not yet been announced and will be communicated later.
This is a routine regulatory filing and does not impact the stock price directly. However, it signals that the Q1 FY26 earnings announcement is expected soon, which may be of interest to investors tracking the company's quarterly performance.